FACTORS AFFECTING USE OF VANCOMYCIN IN CHILDREN

Mạnh Tuấn Hà

Main Article Content

Abstract

Objectives: To investigate the factors affecting the safe and effective use of vancomycin in the treatment of severe infections in children. Methods: A descriptive cross-sectional study was conducted in pediatric patients who indicated vancomycin for more than 3 days. Trough vancomycin levels and creatinine clearance were measured to monitor the efficacy and safety of vancomycin use in these cases. Results: The study enrolled 40 cases. The average dose of vancomycin used was 55.83 ± 19.34 mg/kg/day. The median trough vancomycin concentration was 11.09 (7.84 – 16.46) μg/ml. The mean creatinine clearance was 80.18 ± 29.14 ml/min. Factors influencing the safe and effective use of vancomycin were vancomycin dose, way of vancomycin administration, and creatinine clearance. Conclusion: It is necessary to consider adjusting the dose of vancomycin, the way of vancomycin use according to creatinine clearance and trough vancomycin concentration to ensure safety and effectiveness in treatment

Article Details

References

Rybak, M., et al., Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm, 2009. 66(1): p. 82-98.
2. Tongsai, S. and P. Koomanachai, The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis. BMC Res Notes, 2016. 9(1): p. 455.
3. Chia Ning Chang, W.T.L., Ming Chin Chan, Chih Chien Wang, A Retrospective Study to Estimate Serum Vancomycin Trough Concentrations in Pediatric Patients with Current Recommended Dosing Regimen. Journal of Medical Sciences, 2018. 38: p. 275-279.
4. Frymoyer, A., et al., Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J, 2009. 28(5): p. 398-402.
5. Rajon, K., et al., Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review. Pharm Pract (Granada), 2017. 15(2): p. 887.
6. Dolan, E., et al., Effect of Vancomycin Loading Doses on the Attainment of Target Trough concentrations in Hospitalized Children. J Pediatr Pharmacol Ther, 2020. 25(5): p. 423-430.